Product
OPC-34712FUM
Aliases
OPC-34712FUM/ Brexpiprazole fumarate
3 clinical trials
1 indication
Indication
SchizophreniaClinical trial
A Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Investigate the Efficacy and Safety of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute SchizophreniaStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
A Multicenter, Uncontrolled, Open-label Trial to Investigate the Long-term Tolerability, Safety, and Efficacy of Brexpiprazole Once-weekly (QW) Formulation Administered Once Weekly for 52 Weeks in Patients With SchizophreniaStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Multicenter, Randomized, Open-label, 2-arm, 2-period Crossover Trial to Investigate the Effects of Food on the Pharmacokinetics of a Single Dose of Brexpiprazole Once-weekly (QW) Formulation in Patients With SchizophreniaStatus: Recruiting, Estimated PCD: 2025-01-01